Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?
Rigel Pharmaceuticals Ownership Summary
Rigel Pharmaceuticals is owned by 89.82% institutional investors, 3.36% insiders, and 6.82% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.54% of RIGL shares. Avantis US Small Cap Value ETF is the top mutual fund, with 5.02% of its assets in Rigel Pharmaceuticals shares.
RIGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rigel Pharmaceuticals | 89.82% | 3.36% | 6.82% |
| Sector | Healthcare Stocks | 246.48% | 12.12% | -158.60% |
| Industry | Biotech Stocks | 384.82% | 11.76% | -296.58% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 1.94M | 10.54% | $75.89M |
| Soleus capital management | 1.84M | 10.01% | $72.12M |
| Armistice capital | 1.67M | 9.08% | $65.41M |
| Vanguard group | 1.04M | 5.76% | $44.48M |
| State street | 1.04M | 5.65% | $40.68M |
| Vanguard capital management | 785.11K | 4.26% | $30.71M |
| American century companies | 741.72K | 4.03% | $29.02M |
| Lsv asset management | 721.67K | 3.92% | $28.23M |
| Capitolis liquid global markets | 591.55K | 3.31% | $16.76M |
| Acadian asset management | 591.69K | 3.21% | $23.14M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cm management | 250.00K | 6.21% | $9.78M |
| Soleus capital management | 1.84M | 2.49% | $72.12M |
| Armistice capital | 1.67M | 0.80% | $65.41M |
| Globeflex capital l p | 112.67K | 0.56% | $4.41M |
| Summerhaven investment management | 21.49K | 0.38% | $1.03M |
| Pharvision advisers | 20.52K | 0.33% | $581.39K |
| Virtus investment advisers | 35.40K | 0.32% | $1.38M |
| Capitolis liquid global markets | 591.55K | 0.13% | $16.76M |
| Hennion & walsh asset management | 90.82K | 0.13% | $4.37M |
| Diadema partners lp | 22.82K | 0.11% | $892.56K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | 1.84M | 2.49% | 1.83M |
| Assenagon asset management | 535.68K | 0.03% | 535.68K |
| Armistice capital | 1.67M | 0.80% | 392.00K |
| American century companies | 741.72K | 0.01% | 197.29K |
| Macquarie management | 195.00K | 0.01% | 195.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | - | - | -14.80M |
| Nuveen asset management | - | - | -3.22M |
| Healthcare of ontario pension plan trust fund | - | - | -1.36M |
| Stonepine capital management | - | - | -1.04M |
| Qube research | - | - | -343.90K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Assenagon asset management | 535.68K | 0.03% | 535.68K | $25.79M |
| Macquarie management | 195.00K | 0.01% | 195.00K | $7.63M |
| Sixth street partners management company | 154.63K | 0.00% | 154.63K | $6.05M |
| Axa investment managers | 32.59K | 0.00% | 32.59K | $923.39K |
| Summerhaven investment management | 21.49K | 0.38% | 21.49K | $1.03M |
Sold Out
| Holder | Change |
|---|---|
| International assets investment management | -7.00 |
| Financial consulate | -10.00 |
| Caitong asset management | -13.00 |
| Synergy asset management | -15.00 |
| Frazier financial advisors | -18.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 160 | 3.23% | 16,538,299 | 3.34% | 89 | 1.19% | 88 | 2.33% | 54 | 22.73% |
| Mar 31, 2026 | 152 | -20.42% | 15,851,405 | -1.52% | 88 | 1.11% | 84 | -24.32% | 43 | -30.65% |
| Dec 31, 2025 | 45 | -73.53% | 2,395,282 | -84.02% | 13 | 0.19% | 33 | -68.27% | 9 | -80.43% |
| Sep 30, 2025 | 48 | -61.29% | 2,467,259 | -82.23% | 13 | 0.23% | 24 | -61.90% | 14 | -61.11% |
| Jun 30, 2025 | 123 | 0.82% | 13,882,606 | -0.14% | 77 | 1.27% | 62 | -3.13% | 36 | -5.26% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Avantis US Small Cap Value ETF | 937.75K | 5.02% | 1.72K |
| Vanguard US Total Market Shares ETF | 548.78K | 3.07% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 555.85K | 3.00% | 13.80K |
| Vanguard Total Stock Mkt Idx Inv | 555.85K | 3.00% | 13.80K |
| Vanguard MStar Total Stk Mkt Idx Invest | 555.85K | 2.98% | - |
| State Street® SPDR® S&P® Biotech ETF | 495.10K | 2.65% | -4.00K |
| iShares Russell 2000 ETF | 464.64K | 2.49% | -1.89K |
| SPDR® S&P Biotech ETF | 223.01K | 1.24% | 500.00 |
| Nuveen Quant Small Cap Equity R6 | 213.85K | 1.16% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 212.72K | 1.14% | 364.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Ali-Jackson Kamil | - | Sell | $87.50K |
| May 26, 2026 | Ali-Jackson Kamil | - | Sell | $72.92K |
| Feb 20, 2026 | MOOS WALTER H | - | Sell | $145.44K |
| Feb 04, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $42.60K |
| Feb 05, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $38.02K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | 1 |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
RIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools